Guizhou Yibai Pharmaceutical Co Ltd (600594) — Financial Flexibility Index
Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Financial Flexibility Index of 0.03x as of September 2025. Free cash flow of CN¥40.36 Million (operating CF CN¥33.28 Million minus capex CN¥7.08 Million) represents 0% of total liabilities (CN¥1.32 Billion). Check cash flow reinvestment rate of Guizhou Yibai Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guizhou Yibai Pharmaceutical Co Ltd Financial Flexibility Index (2002–2025)
Historical Financial Flexibility Index trend for Guizhou Yibai Pharmaceutical Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see 600594 cash flow metrics.
Annual Financial Flexibility Index for Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Year-by-year free cash flow to debt coverage for Guizhou Yibai Pharmaceutical Co Ltd. Explore Guizhou Yibai Pharmaceutical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | CN¥291.70 Million | CN¥256.71 Million | CN¥1.17 Billion | ▲ +103.1% |
| 2024 | 0.12x | CN¥183.19 Million | CN¥86.87 Million | CN¥1.49 Billion | ▼ -61.9% |
| 2023 | 0.32x | CN¥507.99 Million | CN¥377.61 Million | CN¥1.58 Billion | ▼ -19.3% |
| 2022 | 0.40x | CN¥668.22 Million | CN¥345.30 Million | CN¥1.68 Billion | ▼ -56.6% |
| 2021 | 0.92x | CN¥1.38 Billion | CN¥934.21 Million | CN¥1.51 Billion | ▲ +112.3% |
| 2020 | 0.43x | CN¥762.40 Million | CN¥366.66 Million | CN¥1.76 Billion | ▲ +45.3% |
| 2019 | 0.30x | CN¥563.99 Million | CN¥362.71 Million | CN¥1.89 Billion | ▲ +42.5% |
| 2018 | 0.21x | CN¥535.62 Million | CN¥214.30 Million | CN¥2.56 Billion | ▼ -50.8% |
| 2017 | 0.42x | CN¥1.08 Billion | CN¥681.78 Million | CN¥2.55 Billion | ▲ +42.7% |
| 2016 | 0.30x | CN¥713.15 Million | CN¥380.62 Million | CN¥2.40 Billion | ▼ -29.6% |
| 2015 | 0.42x | CN¥861.70 Million | CN¥573.68 Million | CN¥2.04 Billion | ▲ +17.5% |
| 2014 | 0.36x | CN¥745.52 Million | CN¥541.58 Million | CN¥2.07 Billion | ▼ -46.3% |
| 2013 | 0.67x | CN¥850.72 Million | CN¥577.24 Million | CN¥1.27 Billion | ▼ -1.4% |
| 2012 | 0.68x | CN¥497.66 Million | CN¥288.01 Million | CN¥731.33 Million | ▲ +7.8% |
| 2011 | 0.63x | CN¥420.17 Million | CN¥277.83 Million | CN¥665.51 Million | ▲ +163.1% |
| 2010 | 0.24x | CN¥165.32 Million | CN¥115.66 Million | CN¥688.82 Million | ▼ -7.7% |
| 2009 | 0.26x | CN¥148.51 Million | CN¥103.88 Million | CN¥571.26 Million | ▼ -36.0% |
| 2008 | 0.41x | CN¥252.12 Million | CN¥189.26 Million | CN¥620.62 Million | ▲ +386.9% |
| 2007 | 0.08x | CN¥50.92 Million | CN¥11.94 Million | CN¥610.24 Million | ▼ -58.4% |
| 2006 | 0.20x | CN¥112.78 Million | CN¥95.77 Million | CN¥562.27 Million | ▲ +33.1% |
| 2005 | 0.15x | CN¥98.37 Million | CN¥17.38 Million | CN¥652.65 Million | ▼ -15.7% |
| 2004 | 0.18x | CN¥64.60 Million | CN¥-44.80 Million | CN¥361.10 Million | ▼ -81.2% |
| 2003 | 0.95x | CN¥261.57 Million | CN¥92.10 Million | CN¥274.93 Million | ▲ +73.4% |
| 2002 | 0.55x | CN¥95.96 Million | CN¥73.46 Million | CN¥174.87 Million | — |